YU60493A - Novi preparati na bazi nomegestrol derivata i postupci za njihovo dobivanje - Google Patents

Novi preparati na bazi nomegestrol derivata i postupci za njihovo dobivanje

Info

Publication number
YU60493A
YU60493A YU60493A YU60493A YU60493A YU 60493 A YU60493 A YU 60493A YU 60493 A YU60493 A YU 60493A YU 60493 A YU60493 A YU 60493A YU 60493 A YU60493 A YU 60493A
Authority
YU
Yugoslavia
Prior art keywords
new
nomegestrol
procedures
production
derivative products
Prior art date
Application number
YU60493A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
M. Lanquetin
J.L. Thomas
J. Paris
E. Coutinho
Original Assignee
Laboratoire Thermex S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Thermex S.A. filed Critical Laboratoire Thermex S.A.
Publication of YU60493A publication Critical patent/YU60493A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
YU60493A 1992-09-21 1993-09-21 Novi preparati na bazi nomegestrol derivata i postupci za njihovo dobivanje YU60493A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9211422A FR2695826B1 (fr) 1992-09-21 1992-09-21 Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.

Publications (1)

Publication Number Publication Date
YU60493A true YU60493A (sh) 1997-01-08

Family

ID=9433868

Family Applications (1)

Application Number Title Priority Date Filing Date
YU60493A YU60493A (sh) 1992-09-21 1993-09-21 Novi preparati na bazi nomegestrol derivata i postupci za njihovo dobivanje

Country Status (31)

Country Link
US (1) US5565443A (en:Method)
EP (1) EP0613372B1 (en:Method)
JP (1) JPH08506318A (en:Method)
KR (1) KR100255700B1 (en:Method)
CN (1) CN1095667C (en:Method)
AP (1) AP497A (en:Method)
AT (1) ATE198275T1 (en:Method)
AU (1) AU683423B2 (en:Method)
BG (1) BG62317B1 (en:Method)
BR (1) BR9305642A (en:Method)
CA (1) CA2122827A1 (en:Method)
CZ (1) CZ284806B6 (en:Method)
DE (1) DE69329790D1 (en:Method)
DZ (1) DZ1717A1 (en:Method)
EC (1) ECSP930986A (en:Method)
FI (1) FI942272A0 (en:Method)
FR (1) FR2695826B1 (en:Method)
HU (1) HUT67044A (en:Method)
IL (1) IL107039A (en:Method)
MA (1) MA22978A1 (en:Method)
NO (1) NO306238B1 (en:Method)
OA (1) OA09924A (en:Method)
PL (1) PL176120B1 (en:Method)
RO (1) RO115783B1 (en:Method)
RU (1) RU2120797C1 (en:Method)
SK (1) SK54694A3 (en:Method)
TN (1) TNSN93104A1 (en:Method)
TW (1) TW381024B (en:Method)
WO (1) WO1994006437A1 (en:Method)
YU (1) YU60493A (en:Method)
ZA (1) ZA936964B (en:Method)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
US6117441A (en) * 1998-07-02 2000-09-12 The Population Council, Inc. Silicone core long term androgen delivery implant
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
GB2355728A (en) * 1999-10-27 2001-05-02 Anson Medical Ltd Tubular medical implants and methods of manufacture
EP1323431B1 (en) 2000-08-03 2010-10-27 Antares Pharma IPL AG Composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
WO2005039531A1 (en) 2003-10-10 2005-05-06 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
CA2452412C (en) 2001-06-29 2011-05-24 Medgraft Microtech, Inc. Biodegradable injectable implants and related methods of manufacture and use
WO2003101358A1 (en) * 2002-05-31 2003-12-11 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of buprenorphine
ZA200507877B (en) * 2003-03-31 2007-01-31 Titan Pharmaceuticals Inc Implantable polymeric device for sustained release of dopamine agonist
JP2007502866A (ja) * 2003-05-30 2007-02-15 タイタン ファーマシューティカルズ インコーポレイテッド ナルメフェンの持続的放出のための移植可能ポリマー装置
US7425340B2 (en) 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
ES2432556T3 (es) 2004-08-04 2013-12-04 Evonik Corporation Métodos para fabricar dispositivos de suministro y sus dispositivos
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
CN101426475A (zh) 2006-04-21 2009-05-06 安塔雷斯制药Ipl股份公司 使用用于经皮或经粘膜应用的制剂治疗热潮红的方法
FR2904213B1 (fr) * 2006-07-27 2008-10-10 Creaspine Soc Par Actions Simp Implant intervertebral destine a la fusion osseuse
US8728528B2 (en) 2007-12-20 2014-05-20 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
GB2555373A (en) * 2016-08-23 2018-05-02 Reproductive Medicine And Gynaecology Associates Ltd Implant

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147783A (en) * 1974-02-28 1979-04-03 Akzona Incorporated Oral pharmaceutical preparation
GB1515284A (en) * 1974-05-21 1978-06-21 Gastaud J Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series
US4172132A (en) * 1977-07-26 1979-10-23 Schering Corporation 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
HU182775B (en) * 1981-10-15 1984-03-28 Richter Gedeon Vegyeszet Process for preparing new 3-chloro-pregnane derivatives
US5223492A (en) * 1987-10-27 1993-06-29 Nasraoui Nejib M Derivatives of 19-nor progesterone; process for producing them and the pharmaceutical compositions incorporating them
FR2664895B1 (fr) * 1990-07-20 1992-10-30 Theramex Laboratoire Nouveaux derives de la 6-methyl 19-nor progesterone, substitues en 3 et leur procede d'obtention.

Also Published As

Publication number Publication date
US5565443A (en) 1996-10-15
CZ116494A3 (en) 1995-03-15
EP0613372B1 (fr) 2000-12-27
TW381024B (en) 2000-02-01
AP9300576A0 (en:Method) 1993-10-31
SK54694A3 (en) 1994-10-05
IL107039A (en) 1999-01-26
JPH08506318A (ja) 1996-07-09
NO941900L (no) 1994-05-24
ATE198275T1 (de) 2001-01-15
AU683423B2 (en) 1997-11-13
AU4822993A (en) 1994-04-12
FR2695826B1 (fr) 1995-01-06
HUT67044A (en) 1995-01-30
RO115783B1 (ro) 2000-06-30
RU2120797C1 (ru) 1998-10-27
NO941900D0 (no) 1994-05-20
FI942272A7 (fi) 1994-05-16
MA22978A1 (fr) 1994-04-01
CA2122827A1 (fr) 1994-03-31
BR9305642A (pt) 1996-01-09
FR2695826A1 (fr) 1994-03-25
IL107039A0 (en) 1993-12-28
OA09924A (fr) 1994-09-15
HU9401395D0 (en) 1994-08-29
NO306238B1 (no) 1999-10-11
DZ1717A1 (fr) 2002-02-17
DE69329790D1 (de) 2001-02-01
EP0613372A1 (fr) 1994-09-07
FI942272L (fi) 1994-05-16
AP497A (en) 1996-05-28
WO1994006437A1 (fr) 1994-03-31
BG62317B1 (bg) 1999-08-31
CZ284806B6 (cs) 1999-03-17
KR100255700B1 (ko) 2000-08-01
TNSN93104A1 (fr) 1994-03-17
CN1095667C (zh) 2002-12-11
BG98776A (bg) 1995-02-28
ECSP930986A (es) 1994-04-12
CN1094284A (zh) 1994-11-02
FI942272A0 (fi) 1994-05-16
PL176120B1 (pl) 1999-04-30
ZA936964B (en) 1994-04-14

Similar Documents

Publication Publication Date Title
YU60493A (sh) Novi preparati na bazi nomegestrol derivata i postupci za njihovo dobivanje
DE69214732T2 (de) Heilender Wundverband
ATE262889T1 (de) Verfahren zur herstellung von implantaten, die leuprolid enthalten
AU3763195A (en) Differentially biodegradable biomedical implants
IL113423A0 (en) Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo utilizing amphipathic peptides and compositions therefor
ES2184895T3 (es) Sistema no polimerico de administracion con liberacion retardada.
AU697761B2 (en) Decontaminating blood components with 8-methoxypsoralen
AU3405895A (en) Delivery of exogenous chemical substances to plant tissues
GR3036188T3 (en) Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
AU3901085A (en) Process for the manufacture of collagen tubes in particular small diameter tubes and application of the tubes obtained in the field of vascular prostheses and nerve sutures
ATE393831T1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
ATE242960T1 (de) Vorrichtung und verfahren zur photoaktivierung
MY110734A (en) Improvements in or relating to dioic acids.
PL348917A1 (en) Absorbent articles
BR0112361A (pt) Métodos para tratamento de condições oculares mediadas por inflamação
AU4381793A (en) Gel composition for implant prosthesis and method of use
CA2159449A1 (en) Oesteoblast Growth Stimulating Composition Containing PDGF and Vitamin D
AU4104397A (en) Implant consisting of a carrier material containing medical substances and method to produce such an implant
EP1374914B1 (de) Verfahren zur Keimreduktion von Abformmaterialien
CA2250880A1 (en) Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof
RU94046022A (ru) Спирты в качестве открывателей калиевых каналов, полезные для лечения недержания мочи, способ их получения, фармкомпозиция
Leonardo et al. A comparison of subcutaneous connective tissue responses among three different formulations of gutta‐percha used in thermatic techniques
EP0845993B1 (de) Verwendung von plasminogenaktivatoren zum lokalen knochenaufbau
RU94028944A (ru) Способ получения косметического средства для ухода за кожей
EP0604774B1 (de) Verwendung eines Gemischs aus Calciumhydroxid und Oleum pedum tauri zur Kollagenneubildung in vivo